| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |